Webinars

PELOAcademy | Unlocking potential with serum-free, animal-free and chemically defined media

presented by Dr. Lothar Steeb, CEO/CSO PELOBiotech
 
The future of cell culture is here—free from animal-derived components, yet richer in performance. Join us to explore how serum-free, animal-free, and chemically defined media are revolutionizing bioprocessing, from research to scalable production. Discover Cellovations’ solutions, case studies and practical strategies to transition seamlessly while maintaining cell viability & productivity.

PELOAcademy | Lisado de Plaquetas Humanas – Productos Clave para la Investigación con Células Madre Mesenquimales (MSCs)

presented by Dr. Julian Olmos, International Sales Manager PELOBiotech

Lisado de Plaquetas Humanas – Productos Clave para la Investigación con Células Madre Mesenquimales (MSCs)

PELOAcademy | Lizat płytek krwi ludzkiej – kluczowe produkty do badań nad MSCs

presented by Dr. Julian Olmos, International Sales Manager PELOBiotech

Lizat płytek krwi ludzkiej – kluczowe produkty do badań nad MSCs

PELOAcademy | Organ-on-Chip: Next-Gen human models for drug research

presented by Dr. Madalena Cipriano and Silke Riegger, 3R Network Tübingen

Highlighting how Organ-on-Chip technology is transforming pharmaceutical research and paving the way for personalized medicine through advanced human model systems.

PELOAcademy | Organoids: Insights into Cancer Treatment

presented by Dr. Ralf Horres, CEO GenXPro, Frankfurt
Exploring how organoid technology is revolutionizing cancer research and therapy.

Discover how these 3D cellular models are being used to simulate tumor environments, test personalized treatments, and accelerate drug discovery.

PELOAcademy | EVs Unpacked: Innovative Tools for Extracellular Vesicle Isolation

presented by Prof. Dr. Irina Nazarenko, UK Freiburg

Recording will be available after June 2025

We present a workflow combining high-purity EV isolation, a software for standardized size and concentration analysis across different instruments, and the new Protein Interaction Coupling assay for absolute biomarker quantification at the single-vesicle level directly in a reaction tube. The result: accessible, scalable solution advancing EV-based liquid biopsy&precision medicine.

PELOAcademy | Cardiac Organoids: From Generation to Application

Presented by Dr. Seon-In Hwang, leader of organoid team at Nexel Co., Seoul, South Korea

This webinar will highlight a 3D cardiac organoid platform developed using human iPSCs to accelerate the functional maturation of cardiomyocytes. The system enhances electrophysiological performance and contractility through multicellular organization and three-dimensional culture conditions. The study supports the platform’s potential use in cardiac toxicity screening, disease modeling, and preclinical applications. No recording available.

PELOAcademy | Human-based biomaterials: The missing link for more predictive 3D Cell Culture

Presented by Dr. Ana Rufino, Senior Researcher, Metatissue, Portugal

We present human protein-derived alternatives, focusing on human methacryloyl platelet lysates (hPLMA), a fully human, tunable biomaterial that overcomes the limits of conventional ECM substitutes. hPLMA-based scaffolds (hydrogels, sponges, microparticles) enable FBS-free culture, maintaining cell viability, proliferation, and differentiation across various cell types.

PELOAcademy | Scaled MSC Cultivation for EV Production using CDM-Challenges and Pitfalls

Presented by Dr. Tanja Kutzner, UK Essen

This webinar explores the journey to GMP-compliant EV manufacturing using clonally immortalized MSCs (ciMSCs). Tanja shares insights on CDM vs. hPL media, challenges in 2D and 3D culture transitions, and key hurdles in EV production, scale-up, and purification. Learn the lessons, pitfalls, and practical strategies from real-world CDM-based EV production.

Role of Nav1.8 Channels in Regulating Excitability of Human DRG Neurons Studied Using Suzetrigine

Presented by Dr. Bruce Bean, Ph.D. Professor of Neurobiology at Harvard Medical School, US

Dr. Bean will present recent findings on the selective Nav1.8 inhibitor, suzetrigine (Journavx), exploring its state- and temperature-dependent effects on neuronal activity. The session will highlight how suzetrigine influences action potential firing and refractory periods at physiological temperatures, offering key insights into the mechanisms of acute pain and the therapeutic potential of targeting Nav1.8 for clinical pain management.

Human-Relevant Vascularized Tissue Models

Presented by James B. Hoying, PhD, Partner and Chief Scientist at Advanced Solutions Life Sciences (ASLS), US and our partner VitaCyte

Date & Time: Thurs, June 19, 25 | 5 PM CEST/11 AM ET

This webinar will explore some of these concepts and avenues by which advanced human-relevant tissue models are employed. An overview of cell sourcing for these models, including vascularization solutions, will be discussed while highlighting solutions to readily build and deploy complex, vascularized tissues for human-relevant tissue modeling and regenerative therapies.

Challenges Facing the Isolation of High-Quality Islets for Total Pancreatectomy with Islet Autotransplantation

Presented by Bashoo Naziruddin, PhD, Director of islet cell processing lab at Baylor UMC Dallas, USA, and our partner VitaCyte

This presentation will highlight the recent progress made by our team in the field of TPIAT with emphasis on the identification of biomarkers for the prediction of good islet yield from the inflamed pancreas and favorable endocrine function during the post-transplant period.